Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 1, Open-Label, Fixed Sequence, Drug-Drug Interaction Study to Evaluate the Effects of Repeat Titrated Doses of Ecopipam on the Pharmacokinetics of Multiple Substrates for Drug Metabolism and Transport in Healthy Subjects

Next Previous
Search
Trial Profile

A Phase 1, Open-Label, Fixed Sequence, Drug-Drug Interaction Study to Evaluate the Effects of Repeat Titrated Doses of Ecopipam on the Pharmacokinetics of Multiple Substrates for Drug Metabolism and Transport in Healthy Subjects

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 22 May 2024

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Atorvastatin (Primary) ; Bupropion (Primary) ; Caffeine (Primary) ; Dabigatran etexilate (Primary) ; Dextromethorphan (Primary) ; Ecopipam (Primary) ; Midazolam (Primary) ; Midazolam (Primary) ; Omeprazole (Primary) ; Pitavastatin (Primary) ; Rosuvastatin (Primary)
  • Indications Gilles de la Tourette's syndrome; Lesch-Nyhan syndrome; Restless legs syndrome; Speech disorders
  • Focus Pharmacokinetics
  • Sponsors Emalex Biosciences

    • Most Recent Events

    • 29 Mar 2024 Results evaluating whether Ecopipam affects Drug Metabolism and Transport of Concomitant Medications, presented at the 125th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics
    • 09 Dec 2022 Status changed from active, no longer recruiting to completed.
    • 18 Aug 2022 Status changed from recruiting to active, no longer recruiting.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top